Prospectus filed under Rule 424(b)(5) - Form 424B5

IR Nav

SEC Filing For null
 AXIM BIOTECHNOLOGIES, INC. - 424B5 (Filed: 18-04-2018) Close Window
Sub Document 1
Page 4: (cont'd)
Page 5: THE OFFERING
Page 6: RISK FACTORS
Page 15: The Investor
Page 19: The Offering
Page 20: RISK FACTORS
Page 26: Clinical trials.
Page 28: Preferred Stock
Page 31: LEGAL MATTERS

Copyright © 2018 QuoteMedia. All rights reserved. Terms of Use.
Market Data powered by QuoteMedia, www.quotemedia.com, SEC filings by Morningstar.